
Sustainability at Roche
Our approach
For over 120 years Roche has been committed to improving lives. The long-term thinking of our founders has allowed us to stay true to this vision. Our greatest contribution to society is lasting innovation. When acting sustainably, we also aim to provide a rewarding workplace, be a trustworthy partner and engage in the communities we work in and with.
The Roche story
The story of Roche underscores our longstanding commitment to creating a partnership between business and science that improves people’s lives.
Our impact on society
Innovating for patients
Providing a great workplace
Being a trustworthy partner
Environment and communities
Delivering continuous growth
Innovating for patients
28.9 million
patients treated with Roche medicines
23.4 billion
tests conducted with Roche Diagnostics products
32 Roche medicines
listed on the WHO Model List of Essential Medicines
Providing a great workplace
68% employee engagement rate
31.9% of women
in key leadership positions
40% of women
on the Corporate Executive Committee
Being a trustworthy partner
92 new partnerships
in Pharmaceuticals in 2020
39 new partnerships
in Diagnostics in 2020
30%
of business critical suppliers audited
Environment and communities
19% decrease
in energy consumption since 2015
26% decrease
in general waste since 2015
28.5% decrease
in water consumption since 2015
Delivering continuous growth
+1%* in Group sales
+4%* in core operating profit
21% of sales invested in R&D
*at constant exchange rate
Explore our stories
External recognition
Our sustainability efforts have been recognised by key ratings such as Dow Jones Sustainability Indices (DJSI) or the Access to Medicine Index (AtMI).

Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI) for the thirteenth year running. This great result is based on an analysis of our economic, social and environmental performance.